ARS Pharmaceuticals, Inc. (SPRY)
8.615
-0.12
(-1.43%)
USD |
NASDAQ |
May 11, 16:00
8.615
0.00 (0.00%)
After-Hours: 19:46
ARS Pharmaceuticals Shareholders Equity (Quarterly) : 114.26M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -217.14M |
| Heron Therapeutics, Inc. | 14.33M |
| Krystal Biotech, Inc. | 1.277B |
| Century Therapeutics, Inc. | 158.94M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 327.65M |
| Total Liabilities (Quarterly) | 213.39M |
| Debt to Equity Ratio | 0.8486 |
| Current Ratio | 7.278 |
| Net Debt Paydown Yield | -1.67% |